
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
10/15/2025 | Q3 | $522.9M | -- | -- | $1.98 | -- |
07/15/2025 | Q2 | $497.3M | -- | -- | $1.91 | -- |
04/14/2025 | Q1 | $478.5M | $407.4M | $1.77 | $1.80 | -$0.03 |
01/21/2025 | Q4 | $470.3M | $425M | $1.91 | $1.78 | $0.13 |
10/15/2024 | Q3 | $458.4M | $407.9M | $1.86 | $1.77 | $0.09 |
07/16/2024 | Q2 | $434.3M | $317.4M | $0.64 | $1.61 | -$0.97 |
04/22/2024 | Q1 | $422.2M | $377.2M | $1.57 | $1.54 | $0.03 |
01/16/2024 | Q4 | $416.4M | $326.3M | $1.19 | $1.67 | -$0.48 |
10/17/2023 | Q3 | -- | -- | $1.69 | $1.70 | -$0.01 |
07/18/2023 | Q2 | -- | -- | $2.54 | $1.64 | $0.90 |
04/17/2023 | Q1 | -- | -- | $1.76 | $1.71 | $0.05 |
01/17/2023 | Q4 | -- | -- | $1.76 | $2.04 | -$0.28 |
10/18/2022 | Q3 | -- | -- | $1.91 | $1.90 | $0.01 |
07/19/2022 | Q2 | -- | -- | $1.86 | $1.67 | $0.19 |
04/18/2022 | Q1 | -- | -- | $1.65 | $1.58 | $0.07 |
01/18/2022 | Q4 | -- | -- | $1.71 | $1.58 | $0.13 |
10/12/2021 | Q3 | -- | -- | $1.75 | $1.55 | $0.20 |
07/20/2021 | Q2 | -- | -- | $1.69 | $1.44 | $0.25 |
04/19/2021 | Q1 | -- | -- | $1.61 | $1.44 | $0.17 |
01/19/2021 | Q4 | -- | -- | $1.42 | $1.35 | $0.07 |
10/20/2020 | Q3 | -- | -- | $1.42 | $1.10 | $0.32 |
07/21/2020 | Q2 | -- | -- | $0.83 | $0.84 | -$0.01 |
04/20/2020 | Q1 | -- | -- | $0.37 | $1.05 | -$0.68 |
01/21/2020 | Q4 | -- | -- | $1.26 | $1.26 | $0.00 |
10/15/2019 | Q3 | -- | -- | $1.44 | $1.35 | $0.09 |
07/16/2019 | Q2 | -- | -- | $1.42 | $1.27 | $0.15 |
04/15/2019 | Q1 | -- | -- | $1.22 | $1.21 | $0.01 |
01/15/2019 | Q4 | -- | -- | $1.25 | $1.23 | $0.02 |
10/16/2018 | Q3 | -- | -- | $1.21 | $1.19 | $0.02 |
07/17/2018 | Q2 | -- | -- | $1.15 | $1.14 | $0.01 |
04/16/2018 | Q1 | -- | -- | $1.13 | $1.10 | $0.03 |
01/17/2018 | Q4 | -- | -- | $0.97 | $0.96 | $0.01 |
10/18/2017 | Q3 | -- | -- | $0.90 | $0.89 | $0.01 |
07/18/2017 | Q2 | -- | -- | $0.84 | $0.79 | $0.05 |
04/17/2017 | Q1 | -- | -- | -- | $0.79 | -- |
01/17/2017 | Q4 | -- | -- | $0.83 | $0.82 | $0.01 |
10/19/2016 | Q3 | -- | -- | $0.78 | $0.79 | -$0.01 |
07/19/2016 | Q2 | -- | -- | $0.75 | $0.74 | $0.01 |
04/18/2016 | Q1 | -- | -- | $0.71 | $0.72 | -$0.01 |
01/19/2016 | Q4 | -- | -- | $0.69 | $0.68 | $0.01 |
10/21/2015 | Q3 | -- | -- | $0.66 | $0.64 | $0.02 |
Pinnacle Financial Partners reported $407.4M worth of top line sales in its most recent quarter.
Pinnacle Financial Partners announced earnings per share of $1.77 which represents a miss of analyst forecast a $1.80 per share.
Pinnacle Financial Partners reported -- that represents -- per share over the last quarter.
Pinnacle Financial Partners's earnings are forecast to grow from $5.96 per share to $6.74 per share next year representing an increase of 31.71%.
Pinnacle Financial Partners's next earnings date is October 15, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.